Patent ReferencesMulticompartmentalized transdermal patches Method for administering the drug deprenyl so as to minimize the danger of side effects Monolithic user-activated transdermal therapeutic system User-activated transdermal therapeutic system Reduction or prevention of sensitization to drugs Treatment of macular degeneration Patent #: 5242950 InventorsAssigneeApplicationNo. 226236 filed on 04/11/1994US Classes:424/449, Transdermal or percutaneous424/448, Pressure sensitive adhesive means514/946PENETRANT OR ABSORBENT (ENHANCES PENETRATION INTO SUBJECT TREATED)ExaminersPrimary: Phelan, D. GabrielleAttorney, Agent or FirmForeign Patent References
International ClassA61L 015/00AbstractThe invention relates to a patch for transdermal administration of volatile pharmaceutically active ingredients of chemically basic nature which comprises a multi-element system comprising(a) a matrix having distributed therein as the drug said volatile active ingredient or a physiologically acceptable salt thereof, the matrix comprising a pressure-sensitive adhesive,(b) an element of a pressure-sensitive adhesive composition which--where (a) contains a salt--contains basic groups to liberate the free base from its salt,(c) a backing layer impermeable to the diffusable ingredients of (a) and (b), and(d) a release liner impermeable to the diffusable ingredients of (a) and (b),matrix (a) or at least a part of (b), whichever is in contact with release liner (d), having a tack sufficient for affixing the patch to the skin, any part of (b) positioned between matrix (a) and release liner (d) being permeable for the deprenyl or the salt thereof or both. The invention also relates to a process for preparing such patch and to a process for treating a patient suffering from Parkinson's or Alzheimer's disease with such patch. | |